View in EDS

O048 : First selective small molecule inhibitor of FGFR4 for the treatment of hepatocellular carcinomas with an activated FGFR4 signaling pathway.

Saved in:
Bibliographic Details
Title: O048 : First selective small molecule inhibitor of FGFR4 for the treatment of hepatocellular carcinomas with an activated FGFR4 signaling pathway.
Authors: Hoeflich, K.1 khoeflich@blueprintmedicines.com, Hagel, M.1, Miduturu, C.1, Sheets, M.1, Rubin, N.1, Weng, W.1, Stransky, N.1, Bifulco, N.1, Kim, J.1, Hodous, B.1, Brooijmans, N.1, Shutes, A.1, Winter, C.2, Lengauer, C.1, Kohl, N.1, Guzi, T.1
Source: Journal of Hepatology. Apr2015 Supplement 2, Vol. 62, pS215-S216. 1p.
Database: Academic Search Ultimate
Description
ISSN:01688278
DOI:10.1016/S0168-8278(15)30062-3